Norges Bank’s GoodRx Holdings GDRX Stock Holding History

Norges Bank’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-705,300	Closed	-$13.6M	–	2096
2022 Q1	$13.6M	Hold	705,300	–	–	﹤0.01%	1586
2021 Q4	$23M	Buy	+705,300	New	+$28.4M	﹤0.01%	1403
2020 Q4	–	Sell	-266,667	Closed	-$14.8M	–	2133
2020 Q3	$14.8M	Buy	+266,667	New	+$14.1M	﹤0.01%	1592

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Norges Bank's GDRX Position: Q2 2022 in Review

Norges Bank sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 705,300 shares — an estimated $13.6M sold.

Norges Bank first reported a position in GDRX in Q3 2020 and held it in 3 quarters. The position peaked at $23M in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Norges Bank reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Norges Bank sold 705,300 GoodRx Holdings shares in Q2 2022, an estimated $13.6M.
Norges Bank first reported a position in GoodRx Holdings in Q3 2020 and held it in 3 quarters.
Norges Bank's GoodRx Holdings position peaked at $23M in Q4 2021.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.